E. Van Braeckel (Ghent, Belgium), S. Chotirmall (Singapore, Singapore)
Clinical application and radiological relavance for Aspergillus fumigatus- and flavus-specific IgG in chronic Pulmonary Aspergillus infection> S. Huang (Taipei, Taiwan), F. Wang (Taipei, Taiwan), S. Li (Taipei, Taiwan), Y. Chan (Taipei, Taiwan), Y. Huang (Taipei, Taiwan), Y. Yang (Taipei, Taiwan)
| |
Cavitary lung lesions – microbiological identification of mycobacteriosis R. Asanov (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), E. Shishkina (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
Characteristic of hydatid cyst in diabetic patients S. Ammari (Ariana, Tunisia), S. Zairi (Ariana, Tunisia), H. Kammoun (Ariana, Tunisia), A. Dridi (Ariana, Tunisia), M. Abdennadher (Ariana, Tunisia), I. Bouassida (Ariana, Tunisia), T. Mestiri (Ariana, Tunisia), L. Megdiche (Ariana, Tunisia), H. Zribi (Ariana, Tunisia), A. Maraghli (Ariana, Tunisia)
| |
Allergic bronchopulmonary aspergillosis as aetiology of bronchiectasis: data from the German bronchiectasis registry PROGNOSIS I. Pink (Hannover, Germany), J. Rademacher (Hannover, Germany), P. Mertsch (Munic, Germany), A. De Roux (Berlin, Germany), A. Zurawski (Hannover, Germany), G. Barten-Neiner (Hannover, Germany), T. Welte (Hannover, Germany), R. Diel (Großhandsdorf, Germany), F. Ringshausen (Hannover, Germany)
| |
Impact of Candida isolation in lower respiratory tract samples on the outcomes of acute exacerbation of chronic obstructive pulmonary disease: a retrospective case-control study Y. Zuo (Shanghai (Xuhui District), China), W. Wang (Shanghai, China), J. Zhang (Shanghai (Xuhui District), China), J. Qu (Shanghai (Xuhui District), China)
| |
Use of Isavuconazole MIC to guide dosing in the management of Aspergillosis in patients with pulmonary disease L. NWANKWO (Fulham, United Kingdom), D. Armstrong-James (Fulham, United Kingdom), A. Shah (Fulham, United Kingdom)
| |
Performance of Siemens immulite immunoassay for detection of Aspergillus fumigatus and Aspergillus flavus specific IgG for chronic pulmonary aspergillosis diagnosis in Pakistan K. Jabeen (Karachi, Pakistan), J. Farooqi (Karachi, Pakistan), N. Iqbal (Karachi, Pakistan), K. Wahab (Karachi, Pakistan), M. Irfan (Karachi, Pakistan)
| |
An open label randomized controlled trial comparing nebulized amphotericin B with oral itraconazole in patients with pulmonary aspergilloma A. Ray (New Delhi, India), J. Manikanta (New Delhi, India), S. Vyas (New Delhi, India), S. Kabra (New Delhi, India)
| |
Clinical characteristics of patients with pulmonary aspergillosis in a respiratory medicine service in southern Brazil F. Westphal (Porto Alegre, Brazil), E. Garcia (Porto Alegre, Brazil), M. Bellon (Porto Alegre, Brazil), T. Franzini (Porto Alegre, Brazil), J. Dallasen (Porto Alegre, Brazil)
| |
Predicting risk of mortality of chronic pulmonary aspergillosis K. Nakamoto (Tokyo, Japan), Y. Sasaki (Tokyo, Japan), T. Shirai (Tokyo, Japan), K. Fujiwara (Tokyo, Japan), K. Furuuchi (Tokyo, Japan), T. Osawa (Tokyo, Japan), M. Shimoda (Tokyo, Japan), K. Morimoto (Tokyo, Japan), Y. Tanaka (Tokyo, Japan), M. Okumura (Tokyo, Japan), T. Yoshiyama (Tokyo, Japan), H. Ogata (Tokyo, Japan), A. Kurashima (Tokyo, Japan), K. Yoshimori (Tokyo, Japan), K. Ohta (Tokyo, Japan)
| |
Comparative evaluation of biological specimens obtained from patients diagnosed with non-tuberculosis mycobacteriosis N. Karpina (Moscow, Russian Federation), I. Shabalina (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), E. Shishkina (Moscow, Russian Federation), R. Asanov (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
An expert statment on clinical considerations before treating NTM lung infection R. Chiron (Montpellier Cedex 5, France), N. Veziris (Paris, France), C. Andrejak (Amiens, France), W. Hoefsloot (Nijmegen, Netherlands), Z. Aoun (Beirut, Lebanon), C. Audoly (Marseille, France), D. Basille (Amiens, France), A. Benattia (Paris, France), A. Bergeron (Paris, France), J. Bervar (Lille, France), J. Boitiaux (Pontoise, France), A. Bourdin (Montpellier, France), D. Bouvry (Paris, France), J. Cadranel (Paris, France), G. Chatté (Caluire, France), L. Colombain (Perpignan, France), J. Couderc (Suresnes, France), B. Crestani (Paris, France), J. Crouzet (Nimes, France), G. Deslee (Reims, France), B. Douvry (Créteil, France), M. Drevait (Montpellier, France), M. Dupuy Grasset (Limoges, France), S. Jouneau (Rennes, France), M. Kerjouan (Rennes, France), S. Leroy (Nice, France), T. Maitre (Paris, France), J. Mallet (Montpellier, France), M. Massongo (Yaounde, Cameroon), M. Murris Espin (Toulouse, France), A. Payet (La Réunion, France), P. Pradère (Clamart, France), A. Prevotat (Lille, France), C. Rogé (Morlaix, France), F. Schlemmer (Paris, France), L. Slim (Ariana, Tunisia), C. Toper (Saint Cloud, France), F. Tritar (Ariana, Tunisia), M. Patrizi (Paris AP HP, France), V. Bouix (Alès, France), F. Blanc (Nantes, France), E. Catherinot (Suresnes, France)
| |
Launch of a novel intrapleural fibrinolytic service for empyema at a district general hospital in London E. Mackay (London, United Kingdom), S. Sasikumar (London, United Kingdom)
| |
Comparison of susceptibility testing results of MAC isolated from HIV-positive andHIV-negative patients A. Panova (Moscow, Russian Federation), A. Gracheva (Moscow, Russian Federation), A. Vinokurov (Moscow, Russian Federation), G. Pay (Moscow, Russian Federation), G. Kaminskiy (Moscow, Russian Federation), E. Karamov (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
In vitro susceptibility testing of bedaquiline against mycobacteria avium-intracellulare complex M. Makarova (Moscow, Russian Federation), . Mikhailova (Moscow, Russian Federation), D. Kudlay (Moscow, Russian Federation), N. Litvinova (Moscow, Russian Federation), L. Guntupova (Moscow, Russian Federation), V. Litvinov (Moscow, Russian Federation)
| |
Pulmonary nocardiosis in renal transplant patients in a tertiary care hospital in Pakistan M. Nazmi (Karachi, Pakistan), F. Haidri (Karachi, Pakistan)
| |
Bacteriological and therapeutic features of lung abscess N. Kallel (Sfax, Tunisia), R. khemakhem (Sfax, Tunisia), K. Abdelmouleh (Sfax, Tunisia), N. Moussa (Sfax, Tunisia), I. Yangui (Sfax, Tunisia), S. Kammoun (Sfax, Tunisia)
| |